D. A. J. Friedman-Klabanoff, Berry, A. A., Travassos, M. A., Cox, C., Zhou, Y., Mo, A. X., Nomicos, E. Y. H., Deye, G. A., Pasetti, M. F., and Laurens, M. B.,
“Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing.”,
Vaccine, vol. S0264-410X(20)31590, 2021.
]